Accustem Sciences IncOTCQB:ACUT
- LAST PRICE0.3299
- TODAY'S CHANGE (%)0.0079 (2.4612%)
- Bid / Lots0.2700/ 25
- Ask / Lots0.4199/ 25
- Open / Previous Close0.3314 / 0.3220
- Day Range
- 52 Week Range
- Volume3,514
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ACUT |
|---|---|---|
| 10:20 ET | 3288 | 0.322 |
| 01:33 ET | 190 | 0.329925 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Accustem Sciences Inc | 3.7M | -2.7x | --- |
Dror Ortho-Design Inc | 4.8M | -1.2x | --- |
Reflect Scientific Inc | 4.0M | -134.1x | --- |
Hawkeye Systems Inc | 2.2M | -2.3x | --- |
Vycor Medical Inc | 2.9M | -4.8x | --- |
Yourspace America Inc | 1.3M | -11.6x | --- |
Company Information
AccuStem Sciences, Inc. is a clinical-stage diagnostics company. The Company is focused on developing and commercializing a suite of genomic tests that support decision-making along the entire continuum of oncology care. The Company's product candidate is StemPrintER, a 20-gene prognostic assay intended to predict the risk of distant recurrence (DR) in luminal (ER+/HER2-negative) breast cancer patients. In addition, the Company is focused on offering ancillary commodity testing (hereditary genetic testing, somatic mutation testing) that augments its assays and provides additional information to patients and physicians throughout the patient care continuum. The Company also holds licensing rights for the MicroRNA Signature Classifier (MSC) test, which is designed to help determine whether lung nodules identified by low-dose computed tomography (LDCT) screening are benign or malignant. The Company's wholly owned subsidiary is StemPrintER Sciences Limited.
Contact Information
- Headquarters
- 5 Penn Plaza, 19th Floor, #1954NEW YORK, NY, United States 10001
- Phone
- 207-066-1000
- Fax
- 302-387-4000
Executives
- Chief Executive Officer, Director
- Wendy Blosser
- Chief Financial Officer
- Keeren Shah
- Chief Operating Officer
- Jeff Fensterer
- Chief Business Officer
- Joe Flanagan
- Director
- Gabriele Cerrone
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 11.3M |
Accustem Sciences Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.12 |
Book Value | $-0.19 |
P/E Ratio | -2.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
